4//SEC Filing
Galena Biopharma, Inc. 4
Accession 0001394548-16-000003
$SLSCIK 0001390478operating
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:26 PM ET
Size
6.2 KB
Accession
0001394548-16-000003
Insider Transaction Report
Form 4
Ghiglieri Stephen F
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-11-01+1,000,000→ 1,000,000 totalExercise: $0.19Exp: 2026-11-01→ Common Stock (1,000,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the Issuer's 2016 Incentive Plan.
- [F2]The Reporting Person obtained the securities pursuant to a new hire Employment Agreement dated November 1, 2016. The securities were convertible into common stock at the rate of 1 share of common stock for each 1 stock option share, or an aggregate 1,000,000 shares of common stock (pre-reverse stock split). The securities were converted into 50,000 stock options at a price of $3.80 (post-reverse stock split) as of November 14, 2016.
- [F3]This stock option vests in equal, quarterly installments over four years, beginning three months after November 1, 2016.
Documents
Issuer
Galena Biopharma, Inc.
CIK 0001390478
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001390478
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:26 PM ET
- Size
- 6.2 KB